This federal contract award, with an ID of SPE2DB20D1004|SPE2DB25FNDNX, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XIFAXAN 550 mg tablets, with a firm fixed price ceiling value of $4,447.32 and a completion date of December 19, 2024. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/19/25, 9:54 AM